Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Earl

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|March 1, 1994
A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancerS Kehoe, C J Poole, A Stanley, et al.
Cancer Research|November 1, 1989
Immunohistochemical study of beta- and kappa-casein in the human breast and breast carcinomas, using monoclonal antibodiesH M Earl, R A McIlhinney, P Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patientsN L Ainsworth, A Marshall, H Hatcher, et al.
The Journal of Pathology|June 1, 1987
T-cell lymphomas in adults: a clinicopathological study of eighteen casesA D Ramsay, W J Smith, H M Earl, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancerS A Amiel, J F Stewart, H M Earl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
A phase II study of Tomudex in relapsed epithelial ovarian cancerM E Gore, H M Earl, J Cassidy, et al.
Sarcoma|June 4, 2008
Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomasH M Earl, S Connolly, C Latoufis, et al.
Biochemical and Biophysical Research Communications|December 26, 1995
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGFB Liu, H M Earl, D Baban, et al.
Molecular and Cellular Endocrinology|November 1, 1988
Mammary gland 1,25-dihydroxyvitamin D3 receptor content during pregnancy and lactationK W Colston, U Berger, P Wilson, et al.
Disability and Rehabilitation|August 23, 2025
Movement difficulties in children with neurodevelopmental disorders: considering a transdiagnostic approach to classificationMatthew C McQueen, Gail A Alvares, Siobhan L Reid, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|March 1, 1994
A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancerS Kehoe, C J Poole, A Stanley, et al.
Cancer Research|November 1, 1989
Immunohistochemical study of beta- and kappa-casein in the human breast and breast carcinomas, using monoclonal antibodiesH M Earl, R A McIlhinney, P Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patientsN L Ainsworth, A Marshall, H Hatcher, et al.
The Journal of Pathology|June 1, 1987
T-cell lymphomas in adults: a clinicopathological study of eighteen casesA D Ramsay, W J Smith, H M Earl, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1984
Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancerS A Amiel, J F Stewart, H M Earl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
A phase II study of Tomudex in relapsed epithelial ovarian cancerM E Gore, H M Earl, J Cassidy, et al.
Sarcoma|June 4, 2008
Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomasH M Earl, S Connolly, C Latoufis, et al.
Biochemical and Biophysical Research Communications|December 26, 1995
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGFB Liu, H M Earl, D Baban, et al.
Molecular and Cellular Endocrinology|November 1, 1988
Mammary gland 1,25-dihydroxyvitamin D3 receptor content during pregnancy and lactationK W Colston, U Berger, P Wilson, et al.
Disability and Rehabilitation|August 23, 2025
Movement difficulties in children with neurodevelopmental disorders: considering a transdiagnostic approach to classificationMatthew C McQueen, Gail A Alvares, Siobhan L Reid, et al.
Pageof 5